Bortezomib–dexamethasone versus high-dose melphalan for Japanese patients with systemic light-chain (AL) amyloidosis: a retrospective single-center study
Crossref DOI link: https://doi.org/10.1007/s12185-016-2128-6
Published Online: 2016-11-10
Published Print: 2017-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Katoh, Nagaaki http://orcid.org/0000-0002-6993-0607
Ueno, Akihiro
Yoshida, Takuhiro
Tazawa, Ko-ichi
Shimojima, Yasuhiro
Gono, Takahisa
Sekijima, Yoshiki
Matsuda, Masayuki
Ikeda, Shu-ichi
License valid from 2016-11-10